fbpx
 

Alzheimer’s

The FDA has recently approved the medication Aducanumab (which is to be given by infusion every four weeks) that studies have shown to slow the decline of cognitive and functional ability of patients (particularly if in the early stages after a diagnosis or those with...

The House of Representatives, with bipartisan support, passed two bills on October 28 that are important to those impacted by Alzheimer’s disease. The Palliative Care and Hospice Education and Training Act (PCHETA) increases the availability and quality of care by creating hospice workforce and palliative...

Skip to content